Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2020

Reconciliation of Numerator and Denominator of Basic and Diluted EPS

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Year Ended December 31,
	2020		2019		2018

Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(116.1)	$	(74.8)	$	(205.7)
Less: Amounts allocated to participating securities (1)	(39.5)		(35.7)		(32.4)
Net loss attributable to common stockholders	$	(155.6)	$	(110.5)	$	(238.1)

Denominator:
Weighted average shares outstanding- basic and diluted (2)	48,776		48,280		48,028

Basic and diluted loss per share (2)	$	(3.19)	$	(2.29)	$	(4.96)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options	712		—		83
Restricted shares	981		67		198

(1)Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.

(2)The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive in each of those periods.